PDB Short entry for 2BEX HEADER HYDROLASE/INHIBITOR 01-DEC-04 2BEX TITLE CRYSTAL STRUCTURE OF PLACENTAL RIBONUCLEASE INHIBITOR IN COMPLEX WITH TITLE 2 HUMAN EOSINOPHIL DERIVED NEUROTOXIN AT 2A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: RIBONUCLEASE INHIBITOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RIBONUCLEASE/ANGIOGENIN INHIBITOR, RAI, RI, RNASE INHIBITOR; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: NONSECRETORY RIBONUCLEASE; COMPND 7 CHAIN: C, D; COMPND 8 SYNONYM: EOSINOPHIL DERIVED NEUROTOXIN, RIBONUCLEASE US, RNASE UPI-2, COMPND 9 RIBONUCLEASE 2, RNASE 2; COMPND 10 EC: 3.1.27.5; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PLACENTA; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_COMMON: HUMAN; SOURCE 9 ORGANISM_TAXID: 9606; SOURCE 10 TISSUE: BLOOD; SOURCE 11 CELL: EOSINOPHILS; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE/INHIBITOR, COMPLEX (INHIBITOR-NUCLEASE), RIBONUCLEASE KEYWDS 2 INHIBITOR, EOSINOPHIL DERIVED NEUROTOXIN, RNASE 2, LUECINE-RICH KEYWDS 3 REPEATS, PROTEIN-PROTEIN INTERACTION, MOLECULAR RECOGNITION, KEYWDS 4 HYDROLASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.IYER,D.E.HOLLOWAY,K.KUMAR,R.SHAPIRO,K.R.ACHARYA REVDAT 4 13-DEC-23 2BEX 1 REMARK REVDAT 3 24-FEB-09 2BEX 1 VERSN REVDAT 2 07-APR-05 2BEX 1 TITLE ATOM REVDAT 1 17-MAR-05 2BEX 0 JRNL AUTH S.IYER,D.E.HOLLOWAY,K.KUMAR,R.SHAPIRO,K.R.ACHARYA JRNL TITL MOLECULAR RECOGNITION OF HUMAN EOSINOPHIL-DERIVED NEUROTOXIN JRNL TITL 2 (RNASE 2) BY PLACENTAL RIBONUCLEASE INHIBITOR JRNL REF J.MOL.BIOL. V. 347 637 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 15755456 JRNL DOI 10.1016/J.JMB.2005.01.035 REMARK 2 REMARK 2 RESOLUTION. 1.99 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.99 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.9 REMARK 3 NUMBER OF REFLECTIONS : 84451 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.800 REMARK 3 FREE R VALUE TEST SET COUNT : 3349 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.99 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.34 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7659 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2555 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 264 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 616 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.45400 REMARK 3 B22 (A**2) : -1.45400 REMARK 3 B33 (A**2) : 2.90900 REMARK 3 B12 (A**2) : -1.76100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.194 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.11 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.732 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.730 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.220 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.280 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.950 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 47.01 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : MALONATE.PARAM REMARK 3 PARAMETER FILE 4 : GOL.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : MALONATE.TOP REMARK 3 TOPOLOGY FILE 4 : GOL.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 1 TO 4 IN CHAIN A AND RESIDUES REMARK 3 1-3 OF CHAIN B ARE MISSING FROM THE STRUCTURE. REMARK 4 REMARK 4 2BEX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-DEC-04. REMARK 100 THE DEPOSITION ID IS D_1290021834. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-SEP-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 89545 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.990 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 27.60 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.99 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1A4Y, PDB ENTRY 1GQV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M SODIUM MALONATE, PH 7.0, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.88333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 171.76667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 171.76667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 85.88333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 LEU A 2 REMARK 465 ASP A 3 REMARK 465 ILE A 4 REMARK 465 SER B 1 REMARK 465 LEU B 2 REMARK 465 ASP B 3 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 5 CG CD OE1 NE2 REMARK 470 GLU A 13 CG CD OE1 OE2 REMARK 470 ARG A 340 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 419 CG CD OE1 OE2 REMARK 470 ARG A 422 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 440 CG CD OE1 OE2 REMARK 470 GLU A 441 CB CG CD OE1 OE2 REMARK 470 ASP A 444 CG OD1 OD2 REMARK 470 ARG A 445 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 447 CG CD OE1 NE2 REMARK 470 GLU A 450 CG CD OE1 OE2 REMARK 470 LYS A 451 CG CD CE NZ REMARK 470 ASP A 452 CG OD1 OD2 REMARK 470 ILE B 4 CG1 CG2 CD1 REMARK 470 GLN B 5 CG CD OE1 NE2 REMARK 470 GLN B 10 CG CD OE1 NE2 REMARK 470 GLU B 13 CG CD OE1 OE2 REMARK 470 LYS B 45 CG CD CE NZ REMARK 470 PRO B 55 CG CD REMARK 470 LYS B 85 CG CD CE NZ REMARK 470 GLN B 140 CG CD OE1 NE2 REMARK 470 LYS B 237 CG CD CE NZ REMARK 470 LYS B 270 CG CD CE NZ REMARK 470 ARG B 351 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 358 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 440 CG CD OE1 OE2 REMARK 470 GLU B 441 CG CD OE1 OE2 REMARK 470 ARG B 445 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 447 CG CD OE1 NE2 REMARK 470 LYS B 451 CG CD CE NZ REMARK 470 ASP B 452 CG OD1 OD2 REMARK 470 LYS C 66 CG CD CE NZ REMARK 470 LYS C 69 CG CD CE NZ REMARK 470 GLN C 91 CG CD OE1 NE2 REMARK 470 ARG C 117 CG CD NE CZ NH1 NH2 REMARK 470 ASN D 17 CG OD1 ND2 REMARK 470 ARG D 35 CG CD NE CZ NH1 NH2 REMARK 470 ASN D 53 CG OD1 ND2 REMARK 470 ASN D 65 CG OD1 ND2 REMARK 470 LYS D 66 CG CD CE NZ REMARK 470 THR D 67 OG1 CG2 REMARK 470 LYS D 69 CG CD CE NZ REMARK 470 GLN D 116 CG CD OE1 NE2 REMARK 470 ARG D 117 CG CD NE CZ NH1 NH2 REMARK 470 ILE D 134 CG1 CG2 CD1 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LEU A 427 CG CD1 CD2 REMARK 480 LEU B 427 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 CB ASP A 444 O HOH A 2255 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 56 40.00 -144.83 REMARK 500 ASN A 182 -175.47 55.97 REMARK 500 GLN A 199 69.78 -107.39 REMARK 500 GLU A 353 168.97 65.46 REMARK 500 ASN B 182 -170.16 53.58 REMARK 500 GLU B 353 163.06 69.84 REMARK 500 THR C 46 -159.07 -138.20 REMARK 500 SER C 76 -157.52 -178.95 REMARK 500 SER C 89 72.90 -166.04 REMARK 500 ASN C 92 104.20 -163.04 REMARK 500 ARG C 118 -33.46 -143.12 REMARK 500 SER D 89 66.59 -163.88 REMARK 500 GLN D 116 10.46 -51.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2010 DISTANCE = 6.45 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MAK B1461 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1461 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1A4Y RELATED DB: PDB REMARK 900 RIBONUCLEASE INHIBITOR-ANGIOGENIN COMPLEX REMARK 900 RELATED ID: 1GQV RELATED DB: PDB REMARK 900 ATOMIC RESOLUTION (0.98A) STRUCTURE OF EOSINOPHIL-DERIVED NEUROTOXIN REMARK 900 RELATED ID: 1HI2 RELATED DB: PDB REMARK 900 EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - SULPHATE COMPLEX REMARK 900 RELATED ID: 1HI3 RELATED DB: PDB REMARK 900 EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE -2'-5'-DIPHOSPHATE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1HI4 RELATED DB: PDB REMARK 900 EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE -3'-5'-DIPHOSPHATE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1HI5 RELATED DB: PDB REMARK 900 EOSINOPHIL-DERIVED NEUROTOXIN (EDN) - ADENOSINE -5'-DIPHOSPHATE REMARK 900 COMPLEX REMARK 900 RELATED ID: 1K2A RELATED DB: PDB REMARK 900 MODIFIED FORM OF EOSINOPHIL-DERIVED NEUROTOXIN DBREF 2BEX A 1 460 UNP P13489 RINI_HUMAN 1 460 DBREF 2BEX B 1 460 UNP P13489 RINI_HUMAN 1 460 DBREF 2BEX C 0 0 PDB 2BEX 2BEX 0 0 DBREF 2BEX C 1 134 UNP P10153 RNKD_HUMAN 28 161 DBREF 2BEX D 0 0 PDB 2BEX 2BEX 0 0 DBREF 2BEX D 1 134 UNP P10153 RNKD_HUMAN 28 161 SEQRES 1 A 460 SER LEU ASP ILE GLN SER LEU ASP ILE GLN CYS GLU GLU SEQRES 2 A 460 LEU SER ASP ALA ARG TRP ALA GLU LEU LEU PRO LEU LEU SEQRES 3 A 460 GLN GLN CYS GLN VAL VAL ARG LEU ASP ASP CYS GLY LEU SEQRES 4 A 460 THR GLU ALA ARG CYS LYS ASP ILE SER SER ALA LEU ARG SEQRES 5 A 460 VAL ASN PRO ALA LEU ALA GLU LEU ASN LEU ARG SER ASN SEQRES 6 A 460 GLU LEU GLY ASP VAL GLY VAL HIS CYS VAL LEU GLN GLY SEQRES 7 A 460 LEU GLN THR PRO SER CYS LYS ILE GLN LYS LEU SER LEU SEQRES 8 A 460 GLN ASN CYS CYS LEU THR GLY ALA GLY CYS GLY VAL LEU SEQRES 9 A 460 SER SER THR LEU ARG THR LEU PRO THR LEU GLN GLU LEU SEQRES 10 A 460 HIS LEU SER ASP ASN LEU LEU GLY ASP ALA GLY LEU GLN SEQRES 11 A 460 LEU LEU CYS GLU GLY LEU LEU ASP PRO GLN CYS ARG LEU SEQRES 12 A 460 GLU LYS LEU GLN LEU GLU TYR CYS SER LEU SER ALA ALA SEQRES 13 A 460 SER CYS GLU PRO LEU ALA SER VAL LEU ARG ALA LYS PRO SEQRES 14 A 460 ASP PHE LYS GLU LEU THR VAL SER ASN ASN ASP ILE ASN SEQRES 15 A 460 GLU ALA GLY VAL ARG VAL LEU CYS GLN GLY LEU LYS ASP SEQRES 16 A 460 SER PRO CYS GLN LEU GLU ALA LEU LYS LEU GLU SER CYS SEQRES 17 A 460 GLY VAL THR SER ASP ASN CYS ARG ASP LEU CYS GLY ILE SEQRES 18 A 460 VAL ALA SER LYS ALA SER LEU ARG GLU LEU ALA LEU GLY SEQRES 19 A 460 SER ASN LYS LEU GLY ASP VAL GLY MET ALA GLU LEU CYS SEQRES 20 A 460 PRO GLY LEU LEU HIS PRO SER SER ARG LEU ARG THR LEU SEQRES 21 A 460 TRP ILE TRP GLU CYS GLY ILE THR ALA LYS GLY CYS GLY SEQRES 22 A 460 ASP LEU CYS ARG VAL LEU ARG ALA LYS GLU SER LEU LYS SEQRES 23 A 460 GLU LEU SER LEU ALA GLY ASN GLU LEU GLY ASP GLU GLY SEQRES 24 A 460 ALA ARG LEU LEU CYS GLU THR LEU LEU GLU PRO GLY CYS SEQRES 25 A 460 GLN LEU GLU SER LEU TRP VAL LYS SER CYS SER PHE THR SEQRES 26 A 460 ALA ALA CYS CYS SER HIS PHE SER SER VAL LEU ALA GLN SEQRES 27 A 460 ASN ARG PHE LEU LEU GLU LEU GLN ILE SER ASN ASN ARG SEQRES 28 A 460 LEU GLU ASP ALA GLY VAL ARG GLU LEU CYS GLN GLY LEU SEQRES 29 A 460 GLY GLN PRO GLY SER VAL LEU ARG VAL LEU TRP LEU ALA SEQRES 30 A 460 ASP CYS ASP VAL SER ASP SER SER CYS SER SER LEU ALA SEQRES 31 A 460 ALA THR LEU LEU ALA ASN HIS SER LEU ARG GLU LEU ASP SEQRES 32 A 460 LEU SER ASN ASN CYS LEU GLY ASP ALA GLY ILE LEU GLN SEQRES 33 A 460 LEU VAL GLU SER VAL ARG GLN PRO GLY CYS LEU LEU GLU SEQRES 34 A 460 GLN LEU VAL LEU TYR ASP ILE TYR TRP SER GLU GLU MET SEQRES 35 A 460 GLU ASP ARG LEU GLN ALA LEU GLU LYS ASP LYS PRO SER SEQRES 36 A 460 LEU ARG VAL ILE SER SEQRES 1 B 460 SER LEU ASP ILE GLN SER LEU ASP ILE GLN CYS GLU GLU SEQRES 2 B 460 LEU SER ASP ALA ARG TRP ALA GLU LEU LEU PRO LEU LEU SEQRES 3 B 460 GLN GLN CYS GLN VAL VAL ARG LEU ASP ASP CYS GLY LEU SEQRES 4 B 460 THR GLU ALA ARG CYS LYS ASP ILE SER SER ALA LEU ARG SEQRES 5 B 460 VAL ASN PRO ALA LEU ALA GLU LEU ASN LEU ARG SER ASN SEQRES 6 B 460 GLU LEU GLY ASP VAL GLY VAL HIS CYS VAL LEU GLN GLY SEQRES 7 B 460 LEU GLN THR PRO SER CYS LYS ILE GLN LYS LEU SER LEU SEQRES 8 B 460 GLN ASN CYS CYS LEU THR GLY ALA GLY CYS GLY VAL LEU SEQRES 9 B 460 SER SER THR LEU ARG THR LEU PRO THR LEU GLN GLU LEU SEQRES 10 B 460 HIS LEU SER ASP ASN LEU LEU GLY ASP ALA GLY LEU GLN SEQRES 11 B 460 LEU LEU CYS GLU GLY LEU LEU ASP PRO GLN CYS ARG LEU SEQRES 12 B 460 GLU LYS LEU GLN LEU GLU TYR CYS SER LEU SER ALA ALA SEQRES 13 B 460 SER CYS GLU PRO LEU ALA SER VAL LEU ARG ALA LYS PRO SEQRES 14 B 460 ASP PHE LYS GLU LEU THR VAL SER ASN ASN ASP ILE ASN SEQRES 15 B 460 GLU ALA GLY VAL ARG VAL LEU CYS GLN GLY LEU LYS ASP SEQRES 16 B 460 SER PRO CYS GLN LEU GLU ALA LEU LYS LEU GLU SER CYS SEQRES 17 B 460 GLY VAL THR SER ASP ASN CYS ARG ASP LEU CYS GLY ILE SEQRES 18 B 460 VAL ALA SER LYS ALA SER LEU ARG GLU LEU ALA LEU GLY SEQRES 19 B 460 SER ASN LYS LEU GLY ASP VAL GLY MET ALA GLU LEU CYS SEQRES 20 B 460 PRO GLY LEU LEU HIS PRO SER SER ARG LEU ARG THR LEU SEQRES 21 B 460 TRP ILE TRP GLU CYS GLY ILE THR ALA LYS GLY CYS GLY SEQRES 22 B 460 ASP LEU CYS ARG VAL LEU ARG ALA LYS GLU SER LEU LYS SEQRES 23 B 460 GLU LEU SER LEU ALA GLY ASN GLU LEU GLY ASP GLU GLY SEQRES 24 B 460 ALA ARG LEU LEU CYS GLU THR LEU LEU GLU PRO GLY CYS SEQRES 25 B 460 GLN LEU GLU SER LEU TRP VAL LYS SER CYS SER PHE THR SEQRES 26 B 460 ALA ALA CYS CYS SER HIS PHE SER SER VAL LEU ALA GLN SEQRES 27 B 460 ASN ARG PHE LEU LEU GLU LEU GLN ILE SER ASN ASN ARG SEQRES 28 B 460 LEU GLU ASP ALA GLY VAL ARG GLU LEU CYS GLN GLY LEU SEQRES 29 B 460 GLY GLN PRO GLY SER VAL LEU ARG VAL LEU TRP LEU ALA SEQRES 30 B 460 ASP CYS ASP VAL SER ASP SER SER CYS SER SER LEU ALA SEQRES 31 B 460 ALA THR LEU LEU ALA ASN HIS SER LEU ARG GLU LEU ASP SEQRES 32 B 460 LEU SER ASN ASN CYS LEU GLY ASP ALA GLY ILE LEU GLN SEQRES 33 B 460 LEU VAL GLU SER VAL ARG GLN PRO GLY CYS LEU LEU GLU SEQRES 34 B 460 GLN LEU VAL LEU TYR ASP ILE TYR TRP SER GLU GLU MET SEQRES 35 B 460 GLU ASP ARG LEU GLN ALA LEU GLU LYS ASP LYS PRO SER SEQRES 36 B 460 LEU ARG VAL ILE SER SEQRES 1 C 135 MET LYS PRO PRO GLN PHE THR TRP ALA GLN TRP PHE GLU SEQRES 2 C 135 THR GLN HIS ILE ASN MET THR SER GLN GLN CYS THR ASN SEQRES 3 C 135 ALA MET GLN VAL ILE ASN ASN TYR GLN ARG ARG CYS LYS SEQRES 4 C 135 ASN GLN ASN THR PHE LEU LEU THR THR PHE ALA ASN VAL SEQRES 5 C 135 VAL ASN VAL CYS GLY ASN PRO ASN MET THR CYS PRO SER SEQRES 6 C 135 ASN LYS THR ARG LYS ASN CYS HIS HIS SER GLY SER GLN SEQRES 7 C 135 VAL PRO LEU ILE HIS CYS ASN LEU THR THR PRO SER PRO SEQRES 8 C 135 GLN ASN ILE SER ASN CYS ARG TYR ALA GLN THR PRO ALA SEQRES 9 C 135 ASN MET PHE TYR ILE VAL ALA CYS ASP ASN ARG ASP GLN SEQRES 10 C 135 ARG ARG ASP PRO PRO GLN TYR PRO VAL VAL PRO VAL HIS SEQRES 11 C 135 LEU ASP ARG ILE ILE SEQRES 1 D 135 MET LYS PRO PRO GLN PHE THR TRP ALA GLN TRP PHE GLU SEQRES 2 D 135 THR GLN HIS ILE ASN MET THR SER GLN GLN CYS THR ASN SEQRES 3 D 135 ALA MET GLN VAL ILE ASN ASN TYR GLN ARG ARG CYS LYS SEQRES 4 D 135 ASN GLN ASN THR PHE LEU LEU THR THR PHE ALA ASN VAL SEQRES 5 D 135 VAL ASN VAL CYS GLY ASN PRO ASN MET THR CYS PRO SER SEQRES 6 D 135 ASN LYS THR ARG LYS ASN CYS HIS HIS SER GLY SER GLN SEQRES 7 D 135 VAL PRO LEU ILE HIS CYS ASN LEU THR THR PRO SER PRO SEQRES 8 D 135 GLN ASN ILE SER ASN CYS ARG TYR ALA GLN THR PRO ALA SEQRES 9 D 135 ASN MET PHE TYR ILE VAL ALA CYS ASP ASN ARG ASP GLN SEQRES 10 D 135 ARG ARG ASP PRO PRO GLN TYR PRO VAL VAL PRO VAL HIS SEQRES 11 D 135 LEU ASP ARG ILE ILE HET GOL A1461 6 HET MAK B1461 8 HETNAM GOL GLYCEROL HETNAM MAK ALPHA-KETOMALONIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 GOL C3 H8 O3 FORMUL 6 MAK C3 H2 O5 FORMUL 7 HOH *616(H2 O) HELIX 1 1 SER A 15 GLN A 27 1 13 HELIX 2 2 THR A 40 ALA A 42 5 3 HELIX 3 3 ARG A 43 ARG A 52 1 10 HELIX 4 4 LEU A 67 GLY A 78 1 12 HELIX 5 5 GLY A 100 ARG A 109 1 10 HELIX 6 6 LEU A 124 LEU A 137 1 14 HELIX 7 7 SER A 157 LYS A 168 1 12 HELIX 8 8 ILE A 181 ASP A 195 1 15 HELIX 9 9 ASP A 213 LYS A 225 1 13 HELIX 10 10 LEU A 238 LEU A 251 1 14 HELIX 11 11 THR A 268 LYS A 282 1 15 HELIX 12 12 LEU A 295 LEU A 308 1 14 HELIX 13 13 CYS A 328 ASN A 339 1 12 HELIX 14 14 LEU A 352 GLY A 365 1 14 HELIX 15 15 SER A 382 ASN A 396 1 15 HELIX 16 16 GLY A 410 ARG A 422 1 13 HELIX 17 17 SER A 439 LYS A 453 1 15 HELIX 18 18 SER B 15 CYS B 29 1 15 HELIX 19 19 THR B 40 VAL B 53 1 14 HELIX 20 20 LEU B 67 GLY B 78 1 12 HELIX 21 21 THR B 97 ALA B 99 5 3 HELIX 22 22 GLY B 100 ARG B 109 1 10 HELIX 23 23 LEU B 124 LEU B 137 1 14 HELIX 24 24 SER B 154 ALA B 156 5 3 HELIX 25 25 SER B 157 LYS B 168 1 12 HELIX 26 26 ILE B 181 SER B 196 1 16 HELIX 27 27 ASP B 213 LYS B 225 1 13 HELIX 28 28 LEU B 238 LEU B 251 1 14 HELIX 29 29 THR B 268 LYS B 282 1 15 HELIX 30 30 LEU B 295 LEU B 308 1 14 HELIX 31 31 CYS B 328 ASN B 339 1 12 HELIX 32 32 LEU B 352 GLY B 365 1 14 HELIX 33 33 SER B 382 ASN B 396 1 15 HELIX 34 34 GLY B 410 ARG B 422 1 13 HELIX 35 35 SER B 439 LYS B 453 1 15 HELIX 36 36 THR C 6 ILE C 16 1 11 HELIX 37 37 GLN C 22 TYR C 33 1 12 HELIX 38 38 THR C 47 CYS C 55 1 9 HELIX 39 39 ASN C 92 CYS C 96 5 5 HELIX 40 40 THR D 6 ILE D 16 1 11 HELIX 41 41 GLN D 22 TYR D 33 1 12 HELIX 42 42 THR D 47 GLY D 56 1 10 HELIX 43 43 ASN D 92 CYS D 96 5 5 SHEET 1 AA17 SER A 6 GLN A 10 0 SHEET 2 AA17 VAL A 31 ASP A 35 1 O VAL A 31 N LEU A 7 SHEET 3 AA17 GLU A 59 ASN A 61 1 O GLU A 59 N VAL A 32 SHEET 4 AA17 LYS A 88 SER A 90 1 O LYS A 88 N LEU A 60 SHEET 5 AA17 GLU A 116 HIS A 118 1 O GLU A 116 N LEU A 89 SHEET 6 AA17 LYS A 145 GLN A 147 1 O LYS A 145 N LEU A 117 SHEET 7 AA17 GLU A 173 THR A 175 1 O GLU A 173 N LEU A 146 SHEET 8 AA17 ALA A 202 LYS A 204 1 O ALA A 202 N LEU A 174 SHEET 9 AA17 GLU A 230 ALA A 232 1 O GLU A 230 N LEU A 203 SHEET 10 AA17 THR A 259 TRP A 261 1 O THR A 259 N LEU A 231 SHEET 11 AA17 GLU A 287 SER A 289 1 O GLU A 287 N LEU A 260 SHEET 12 AA17 SER A 316 TRP A 318 1 O SER A 316 N LEU A 288 SHEET 13 AA17 GLU A 344 GLN A 346 1 O GLU A 344 N LEU A 317 SHEET 14 AA17 VAL A 373 TRP A 375 1 O VAL A 373 N LEU A 345 SHEET 15 AA17 GLU A 401 ASP A 403 1 O GLU A 401 N LEU A 374 SHEET 16 AA17 GLN A 430 VAL A 432 1 O GLN A 430 N LEU A 402 SHEET 17 AA17 ARG A 457 ILE A 459 1 O ARG A 457 N LEU A 431 SHEET 1 BA17 SER B 6 GLN B 10 0 SHEET 2 BA17 VAL B 31 ASP B 35 1 O VAL B 31 N LEU B 7 SHEET 3 BA17 GLU B 59 ASN B 61 1 O GLU B 59 N VAL B 32 SHEET 4 BA17 LYS B 88 SER B 90 1 O LYS B 88 N LEU B 60 SHEET 5 BA17 GLU B 116 HIS B 118 1 O GLU B 116 N LEU B 89 SHEET 6 BA17 LYS B 145 GLN B 147 1 O LYS B 145 N LEU B 117 SHEET 7 BA17 GLU B 173 THR B 175 1 O GLU B 173 N LEU B 146 SHEET 8 BA17 ALA B 202 LYS B 204 1 O ALA B 202 N LEU B 174 SHEET 9 BA17 GLU B 230 ALA B 232 1 O GLU B 230 N LEU B 203 SHEET 10 BA17 THR B 259 TRP B 261 1 O THR B 259 N LEU B 231 SHEET 11 BA17 GLU B 287 SER B 289 1 O GLU B 287 N LEU B 260 SHEET 12 BA17 SER B 316 TRP B 318 1 O SER B 316 N LEU B 288 SHEET 13 BA17 GLU B 344 GLN B 346 1 O GLU B 344 N LEU B 317 SHEET 14 BA17 VAL B 373 TRP B 375 1 O VAL B 373 N LEU B 345 SHEET 15 BA17 GLU B 401 ASP B 403 1 O GLU B 401 N LEU B 374 SHEET 16 BA17 GLN B 430 VAL B 432 1 O GLN B 430 N LEU B 402 SHEET 17 BA17 ARG B 457 ILE B 459 1 O ARG B 457 N LEU B 431 SHEET 1 CA 4 GLN C 40 LEU C 44 0 SHEET 2 CA 4 VAL C 78 THR C 87 -1 O ILE C 81 N PHE C 43 SHEET 3 CA 4 ARG C 97 ASN C 113 -1 O ARG C 97 N THR C 86 SHEET 4 CA 4 CYS C 71 HIS C 73 -1 O HIS C 72 N VAL C 109 SHEET 1 CB 4 GLN C 40 LEU C 44 0 SHEET 2 CB 4 VAL C 78 THR C 87 -1 O ILE C 81 N PHE C 43 SHEET 3 CB 4 ARG C 97 ASN C 113 -1 O ARG C 97 N THR C 86 SHEET 4 CB 4 VAL C 125 ILE C 134 -1 O VAL C 126 N ASP C 112 SHEET 1 DA 4 GLN D 40 LEU D 44 0 SHEET 2 DA 4 VAL D 78 THR D 87 -1 O ILE D 81 N PHE D 43 SHEET 3 DA 4 ARG D 97 ASN D 113 -1 O ARG D 97 N THR D 86 SHEET 4 DA 4 CYS D 71 HIS D 73 -1 O HIS D 72 N VAL D 109 SHEET 1 DB 4 GLN D 40 LEU D 44 0 SHEET 2 DB 4 VAL D 78 THR D 87 -1 O ILE D 81 N PHE D 43 SHEET 3 DB 4 ARG D 97 ASN D 113 -1 O ARG D 97 N THR D 86 SHEET 4 DB 4 VAL D 125 ILE D 134 -1 O VAL D 126 N ASP D 112 SSBOND 1 CYS C 23 CYS C 83 1555 1555 2.03 SSBOND 2 CYS C 37 CYS C 96 1555 1555 2.03 SSBOND 3 CYS C 55 CYS C 111 1555 1555 2.03 SSBOND 4 CYS C 62 CYS C 71 1555 1555 2.03 SSBOND 5 CYS D 23 CYS D 83 1555 1555 2.03 SSBOND 6 CYS D 37 CYS D 96 1555 1555 2.03 SSBOND 7 CYS D 55 CYS D 111 1555 1555 2.03 SSBOND 8 CYS D 62 CYS D 71 1555 1555 2.03 SITE 1 AC1 4 TRP B 263 GLU B 264 HOH B2246 ALA D 99 SITE 1 AC2 6 SER A 105 SER A 106 ARG A 109 LEU A 131 SITE 2 AC2 6 GLU A 134 ASN C 57 CRYST1 91.980 91.980 257.650 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010872 0.006276 -0.000001 0.00000 SCALE2 0.000000 0.012554 -0.000001 0.00000 SCALE3 0.000000 0.000000 0.003881 0.00000